A recent publication identified the histone methyltransferase enhancer of Zeste homology 2 (EZH2), which regulates the lineage commitment of MSCs and, therefore, contributes to the pathology of osteoporosis [55]. The gene discussed is PRDM9; the disease is osteoporosis.